Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease

被引:63
作者
Bergamaschini, L
Parnetti, L
Pareyson, D
Canziani, S
Cugno, M
Agostoni, A
机构
[1] Univ Perugia, Gerontol & Geriatr Unit, I-06100 Perugia, Italy
[2] Natl Inst Neurol Carlo Besta, Milan, Italy
关键词
inflammation; contact system; high molecular weight kininogen; beta-amyloid; factor XII; kallikrein;
D O I
10.1097/00002093-199806000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several converging lines of evidence suggest that beta-amyloid and inflammation may be linked in the pathogenesis of Alzheimer disease (AD), but the mechanism of beta-amyloid neurotoxicity is unclear, in this study, by demonstrating that high molecular weight kininogen may be massively cleaved in the cerebrospinal fluid (CSF) of patients with AD, we provide evidence of the potential involvement of the contact system in the inflammatory processes taking place in this disease. In the CSF of patients with neuroimmune inflammatory disease (multiple sclerosis, chronic inflammatory demyelinating polyneuropathy), there was no evidence of increased cleavage of high molecular weight kininogen, suggesting that this finding maybe characteristic of the Alzheimer brain. The data obtained from in vitro experiments seem to indicate that the cleavage of high molecular weight kininogen in vivo may be the result of the interaction of beta-amyloid with factor XII and of kallikrein generation. The actual relevance of such a phenomenon remains to be established in vivo. However, the demonstration that the contact system may be activated in the brains of Alzheimer patients points to the potential involvement of the kallikrein-kinin system in the inflammatory process of this disease.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 53 条
[31]   IMMUNE-SYSTEM RESPONSE IN ALZHEIMERS-DISEASE [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1989, 16 (04) :516-527
[32]   ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY IN BRAIN-TISSUE OF ALZHEIMER PATIENTS [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
NEUROSCIENCE LETTERS, 1989, 107 (1-3) :341-346
[33]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[34]  
NUIJENS JH, 1988, BLOOD, V72, P1841
[35]   MECHANISM OF SERPIN ACTION - EVIDENCE THAT C1 INHIBITOR FUNCTIONS AS A SUICIDE SUBSTRATE [J].
PATSTON, PA ;
GETTINS, P ;
BEECHEM, J ;
SCHAPIRA, M .
BIOCHEMISTRY, 1991, 30 (36) :8876-8882
[36]   INHIBITION OF PLASMIN PLASMA KALLIKREIN PLASMA PERMEABILITY FACTOR AND C'1R SUBCOMPONENT OF FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR [J].
RATNOFF, OD ;
PENSKY, J ;
OGSTON, D ;
NAFF, GB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (02) :315-&
[37]  
REISBERG B, 1982, AM J PSYCHIAT, V139, P1136
[38]   COMPLEMENT ACTIVATION BY BETA-AMYLOID IN ALZHEIMER-DISEASE [J].
ROGERS, J ;
COOPER, NR ;
WEBSTER, S ;
SCHULTZ, J ;
MCGEER, PL ;
STYREN, SD ;
CIVIN, WH ;
BRACHOVA, L ;
BRADT, B ;
WARD, P ;
LIEBERBURG, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10016-10020
[39]   INHIBITION BY CI/BARINH OF HAGEMAN-FACTOR FRAGMENT ACTIVATION OF COAGULATION, FIBRINOLYSIS, AND KININ GENERATION [J].
SCHREIBER, AD ;
KAPLAN, AP ;
AUSTEN, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (06) :1402-1409
[40]  
SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cellbio.10.1.373